Furthermore, a characteristic clinical symptom of the iMCD-TAFRO syndrome is bone marrow fibrosis; the mechanism of myelofibrosis is believed to be the self-proliferation of cytokine-independent hematopoietic cells by JAK 2 activation. Here, JAK2 is linked to myelofibrosis.